Select City
Ozempic has gained widespread attention globally, not only for its effectiveness in controlling diabetes but in addressing significant weight gain. Recently, CDSCO, the Central Drugs Standard Control Organization, has approved the Ozempic usage in India, which will affect treatment choices and lifestyle changes for a large portion of the population struggling with diabetes and weight gain in India.
Ozempic has gained widespread attention globally, not only for its effectiveness in controlling ... Read More
Free Cab Facility
No-Cost EMI
Support in Insurance Claim
1-day Hospitalization
USFDA-Approved Procedure
Ozempic is the brand name for semaglutide, an injectable medication used once a week and belonging to the GLP-1 receptor agonist class. It functions similarly to the natural hormone GLP-1, which helps in regulating the blood sugar levels in the body. It increases the release of insulin in response to elevated blood glucose levels, decreases incorrect glucagon secretion, delays stomach emptying, and suppresses hunger at higher dosages. In addition to diabetes management, it also supports weight loss, which makes it an effective dual-purpose drug popular worldwide.
Fill details to get actual cost
Ozempic begins by helping the pancreas in releasing insulin when the body struggles with high blood sugar levels. It decreases the secretion of glucagon, thereby preventing the liver from releasing unnecessary sugar into the bloodstream. Gradually, it slows down how quickly the stomach empties after meals, inducing the feeling of fullness for a long time, and reducing overeating.
The CDSCO’s recent approval for the Ozempic usage in India can prove to be a game-changer for people struggling with controlling their blood pressure and managing weight.
Severe healthcare professionals have emphasized that although Ozempic offers several benefits, these must be prescribed carefully and should be consumed under regular monitoring. For maximum results, the doctor may also suggest some lifestyle adjustments.
Although Ozempic has proven to be effective in addressing obesity treatment, several patients have reported various side effects and complications. Gastrointestinal issues such as nausea, fatigue, vomiting, decreased appetite, digestive issues, headache, along with a change in mood and anxiety, are common. Additionally, long-term usage of the medicine has been reported to cause nutritional deficiencies and loss of muscle mass.
In some cases, it may also cause serious side effects such as pancreatitis, kidney issues, and thyroid-related complications. Several others have also reported issues such as mood disturbances, anxiety-related issues, and vision issues that require close monitoring by healthcare professionals.
Diet & Lifestyle Consultation
Post-Surgery Follow-Up
Free Cab Facility
24*7 Patient Support
People with the following health conditions may consider taking the Ozempic injection after consulting a doctor.
You must note that Ozempic is not approved for type 1 diabetes and people with a medical history of thyroid cancers or severe digestive disorders.
The patient is suggested a low dosage(0.25 weekly) initially, and gradually the dosage is increased to 1 mg or higher depending upon the patient’s condition. Additionally, monitoring of thyroid levels, blood sugar levels, kidney functioning, and pancreatic enzymes is also essential in certain individuals.
Depending on the genetics, eating habits, physical activity routine, and the consistency with the drug usage, the weight loss results vary. Some may lose much more, and others may not lose at all. On average, in the starting stage, people begin to lose 5-10% of their initial weight. Higher doses, similar to Wegovy, have shown a 12-15% reduction in the trials.
For maximum and optimal outcomes, you must adhere to the strict and regular healthy lifestyle changes. If the patient doesn’t consume a healthy and nutritious diet, remains inactive, the weight loss and sugar benefits will be limited.
Both medications are being injected to control and regulate the blood sugar levels and help address the weight loss in obese people. These also help in addressing the risk of cardiovascular issues, such as heart attack and stroke. However, there are a few differences given below.
| Classification | Mounjaro | Ozempic |
| Frequency | Once a week | Once a week |
| Class | GLP-1 | GLP-1 and GIP |
| Reusability | Single-use pen | Multi-dose pen |
| Storage | For up to 21 days, at room temperature or inside the fridge | For up to 51 days, at room temperature or inside the fridge |
| Delivery method | Single-use pre-filled pen | Multi-use pre-filled pen |
| Average time taken for
weight loss |
Slow onset | Usually faster results |
| Manufacturer | Novo nordisk | Eli Lilly and Company |
| Dosage | 0.25 – 2 mg weekly | 2.5 – 15 mg weekly |
| Side-effects | Nausea, vomiting, diarrhea, constipation | More intense nausea, diarrhea |
CDSCO’s recent regulatory approval of Ozempic has marked a turning point in addressing diabetes as well as obesity management. The approval allows for a more controlled, safer, and regulated use of Ozempic in India for diabetes management. However, you should always consult a healthcare professional before taking the injection and should avoid taking it on your own. Consult our experts for a more comprehensive understanding of the benefits, side effects, and who should take the Ozempic injection.
Ozempic injection price in India depends on various factors, such as the dosage, pack size, city where the pharmacy is located, etc. Additionally, several factors, such as the future availability of generic options and bulk purchasing, can affect the pricing structure, too.
Ozempic is popular worldwide for its effectiveness in addressing type 2 diabetes and significant weight loss objectives. While there are certain side effects associated, such as nausea, diarrhea, and stomach pain, it is considered to be an effective weight loss medication that works by reducing the appetite.
Although the percentage of weight loss significantly varies from person to person, most patients have reported losing 1-2% of their total body weight.
Liraglutide(Saxenda or Victoza), semaglutide (Ozempic and Wegovy), and tirzepatide(Mounjaro) are the three main types of weight loss injections.
